NEWS      WELCOME      CONTACT EMN      EMN SO      EMN TRIALS      EMN TRIAL GROUP      EMN BIOLOGY GROUP      LOGIN      MSCNET

 Updated on: Jan 9 2014

EMN Trials

 

 

is titled:

 

"A randomized open-label multicenter phase III trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan and Dexamethasone (BMDex) for untreated patients with systemic light-chain (AL) amyloidosis".

 

Read a brief summary of the study here.

Completion of enrolment has been reached - Follow-up of enrolled subjects continues.
 

The trial is registered on Clinicaltrials.gov


A list of key personel involved in the EMN-03 study can be found here.


Click on any of the participating countries on the map below to find contact information on national Investigators, Co-investigator and other participants in the EMN-03 study. Australia has been inserted at the bottom right corner of the map with list of co-investigators.

 

Secr. Hans E. Johnsen | Depart. of Haematology | Aalborg University Hospital | Sdr. Skovvej 15 | DK-9000 Aalborg | Denmark | T:+45 9766 3871 | F:+45 9766 6369